Internal Medicine, Endocrinology, Diabetes, & Metabolism · Marrero, LA
NPI
1205027349
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1111 Medical Center Blvd N713
Marrero, LA, 70072
Phone (504) 393-0088
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
370 services
Medicare patients, 2024
107
Average age 73
Drug cost, 2024
$1.1M
1,836 prescriptions
Company payments, 2025
$73K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marideli C Scanlan was code 99215 (office e&m - established), 96 times for 66 patients. In total Marideli C Scanlan billed 370 services in 12 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 96 | 66 | $114.04 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 86 | 63 | $13.33 | $1,146 |
| 99214 Office E&M - Established | Facility | 63 | 47 | $72.45 | $4,565 |
| 95251 Test - Miscellaneous | Facility | 40 | 18 | $26.11 | $1,044 |
| 99232 Hospital E&M - Subsequent | Facility | 38 | 18 | $63.51 | $2,413 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 34 | 21 | $25.33 | $861 |
By year: 2022 $23K for 328 services; 2023 $19K for 280 services; 2024 $22K for 370 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marideli C Scanlan prescribed most often to Medicare patients was Ozempic (Semaglutide), with 335 prescriptions and refills. In total Marideli C Scanlan wrote 1,836 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 335 | 499 | 78 | $470K |
| Levoxyl Levothyroxine Sodium | 167 | 461 | 56 | $9,291 |
| Metformin Hcl Er Metformin Hcl | 131 | 391 | 45 | $1,273 |
| Mounjaro Tirzepatide | 128 | 144 | 33 | $151K |
| Rosuvastatin Calcium Generic | 86 | 246 | 34 | $1,164 |
| Jardiance Empagliflozin | 85 | 185 | 21 | $107K |
| Levothyroxine Sodium Generic | 71 | 206 | 31 | $989 |
| Repatha Sureclick Evolocumab | 54 | 73 | 11 | $41K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 49 | 103 | Under 11 | $55K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 35 | 76 | 16 | $6,458 |
| Synthroid Levothyroxine Sodium | 34 | 82 | 11 | $3,391 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 29 | 79 | 12 | $501 |
| Trulicity Dulaglutide | 24 | 40 | Under 11 | $38K |
| Atorvastatin Calcium Generic | 23 | 69 | Under 11 | $501 |
| Farxiga Dapagliflozin Propanediol | 22 | 23 | Under 11 | $12K |
Brand drugs: 1,187 claims; generic drugs: 574 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marideli C Scanlan $73K ($73K in general payments such as food, travel and fees) from 21 companies. The largest payer was Lilly USA, LLC with $46K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 71 | $46K |
| Novo Nordisk Inc NVO | 33 | $17K |
| Dexcom, Inc. DXCM | 9 | $6,778 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $1,950 |
| Beta Bionics, Inc. BBNX | 2 | $152 |
| Xeris Pharmaceuticals, Inc. | 5 | $106 |
| Abbott Laboratories ABT | 4 | $96.01 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $52.21 |
| Amgen Inc. AMGN | 2 | $42.95 |
| Corcept Therapeutics CORT | 2 | $42.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.